Director Peter Reikes resigns from Ionis board to join FDA, effective Nov 21, 2021

IONIS PHARMACEUTICALS INC

Peter N. Reikes resigned from the Board of Directors effective November 21, 2021.
Resignation due to accepting a position with the U.S. Food and Drug Administration to avoid a perception of conflict of interest.
No successor has been named to fill the vacancy on the Board.
Company expressed gratitude for Reikes' advice and leadership as a Board member.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Peter N. Reikes

Director

IONS · IONIS PHARMACEUTICALS INC

Effective: 2021-11-21
Filed: November 26, 2021, 6:59 PM ET

On November 19, 2021, Peter N. Reikes, a member of the Board of Directors (“Board”) and Finance Committee of the Board of Ionis Pharmaceuticals, Inc. (the “Company”), notified the Company that he is resigning from the Company’s Board effective November 21, 2021.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Peter N. Reikes resigned as Director at IONIS PHARMACEUTICALS INC.

Action: resigned
Role: Director

Exact text from the filing

On November 19, 2021, Peter N. Reikes, a member of the Board of Directors (“Board”) and Finance Committee of the Board of Ionis Pharmaceuticals, Inc. (the “Company”), notified the Company that he is resigning from the Company’s Board effective November 21, 2021.

View on SEC.gov

IONIS PHARMACEUTICALS INC filing history →

Source: SEC EDGAR

accession 0001140361-21-039510

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.